INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 38 filers reported holding INSMED INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,134,000 | -34.5% | 1,200,000 | -30.6% | 0.96% | -12.0% |
| Q1 2022 | $1,730,000 | -24.7% | 1,730,000 | -22.4% | 1.09% | -27.2% |
| Q4 2021 | $2,297,000 | -0.6% | 2,230,000 | 0.0% | 1.50% | +8.7% |
| Q3 2021 | $2,311,000 | -1.4% | 2,230,000 | 0.0% | 1.38% | +29.0% |
| Q2 2021 | $2,345,000 | +740.5% | 2,230,000 | +792.0% | 1.07% | +502.8% |
| Q1 2021 | $279,000 | -45.2% | 250,000 | -44.4% | 0.18% | -31.1% |
| Q4 2020 | $509,000 | +3.7% | 450,000 | 0.0% | 0.26% | +6.2% |
| Q3 2020 | $491,000 | +11.8% | 450,000 | 0.0% | 0.24% | -18.5% |
| Q2 2020 | $439,000 | -48.4% | 450,000 | -55.0% | 0.30% | -66.1% |
| Q1 2020 | $850,000 | -12.2% | 1,000,000 | 0.0% | 0.88% | +49.2% |
| Q4 2019 | $968,000 | +15.5% | 1,000,000 | 0.0% | 0.59% | +11.0% |
| Q3 2019 | $838,000 | -13.9% | 1,000,000 | 0.0% | 0.53% | -25.1% |
| Q2 2019 | $973,000 | -3.3% | 1,000,000 | 0.0% | 0.71% | -24.9% |
| Q1 2019 | $1,006,000 | +42.1% | 1,000,000 | 0.0% | 0.94% | +40.5% |
| Q4 2018 | $708,000 | -17.0% | 1,000,000 | 0.0% | 0.67% | +32.0% |
| Q3 2018 | $853,000 | -6.8% | 1,000,000 | 0.0% | 0.51% | -22.2% |
| Q2 2018 | $915,000 | – | 1,000,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |